Centessa Pharmaceuticals (CNTA) Research & Development: 2022-2025
Historic Research & Development for Centessa Pharmaceuticals (CNTA) over the last 4 years, with Sep 2025 value amounting to $41.6 million.
- Centessa Pharmaceuticals' Research & Development rose 22.59% to $41.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $178.6 million, marking a year-over-year increase of 49.99%. This contributed to the annual value of $150.2 million for FY2024, which is 20.77% up from last year.
- Latest data reveals that Centessa Pharmaceuticals reported Research & Development of $41.6 million as of Q3 2025, which was down 2.76% from $42.7 million recorded in Q2 2025.
- Over the past 5 years, Centessa Pharmaceuticals' Research & Development peaked at $60.9 million during Q4 2024, and registered a low of $22.7 million during Q1 2024.
- In the last 3 years, Centessa Pharmaceuticals' Research & Development had a median value of $33.4 million in 2025 and averaged $35.7 million.
- Its Research & Development has fluctuated over the past 5 years, first slumped by 37.24% in 2023, then soared by 104.85% in 2024.
- Over the past 4 years, Centessa Pharmaceuticals' Research & Development (Quarterly) stood at $27.8 million in 2022, then grew by 6.76% to $29.7 million in 2023, then spiked by 104.85% to $60.9 million in 2024, then climbed by 22.59% to $41.6 million in 2025.
- Its Research & Development was $41.6 million in Q3 2025, compared to $42.7 million in Q2 2025 and $33.4 million in Q1 2025.